LONDON (Alliance News) - Summit Corporation PLC Tuesday said it will seek shareholder permission for a share consolidation that will see every 20 existing shares consolidated into one new share. In a statement, the drug discovery company said it will first consolidate every 20 shares into o Read More

Summit Corp Loss Widens As Drug Programmes Progress

30th Apr 2014 11:55

LONDON (Alliance News) - Drug company Summit Corporation PLC Wednesday said its loss widened in its last financial year as its research and development costs rose as both its drug programmes moved towards clinical trials. The Oxford-based company is currently developing treatments for Duche Read More

Summit Corporation Gets FDA Approval For Novel Antibiotic Study

18th Mar 2014 13:29

LONDON (Alliance News) - Summit Corporation PLC Tuesday said the US Food and Drug Administration has approved its Investigational New Drug application to initiate a Phase 2 proof of concept study for its novel antibiotic SMT19969 for the treatment of C. difficile infection. In a statement, Read More

Summit Corporation Completes Fund Raising With Over-Subscribed Subscription

26th Feb 2014 11:40

LONDON (Alliance News) - Summit Corporation Wednesday said it raised gross proceeds of GBP1.0 million in an oversubscribed subscription offer, meaning it raised GBP22.0 million through its recent placing and the subscription. In a statement, Summit said it had to scale back allocations afte Read More

UK WINNERS & LOSERS: Airlines Soar, Oil Producers Slip After Iran Deal

25th Nov 2013 11:52

Summit Corp Rises As It Enters Alliance With Oxford University

25th Nov 2013 11:14

1 2 34

FTSE 100 Latest

Value8,809.74

Change53.53